Literature DB >> 86092

Characteristics of patients with schizophrenia or neurological disorder and virus-like agent in cerebrospinal fluid.

T J Crow, I N Ferrier, E C Johnstone, J F Macmillan, D G Owens, R P Parry, D A Tyrrell.   

Abstract

A virus-like agent (V.L.A.) with a cytopathic effect on cultured cells was found in the cerebrospinal fluid of 18 of 47 patients with schizophrenia, of whom 10 had nuclear schizophrenic symptoms. In most patients with V.L.A., blood and C.S.F. protein concentrations were normal. Patients with and without V.L.A. had similar clinical characteristics but serum IgA levels were higher in those with V.L.A. V.L.A. was also detected in the C.S.F. of 8 of 11 patients with serious or chronic neurological disease (Huntington's chorea, multiple sclerosis, and unexplained alterations of consciousness).

Entities:  

Mesh:

Year:  1979        PMID: 86092     DOI: 10.1016/s0140-6736(79)91262-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Search for viral nucleic acid sequences in the post mortem brains of patients with schizophrenia and individuals who have committed suicide.

Authors:  G I Carter; G R Taylor; T J Crow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

Review 2.  The biology of schizophrenia.

Authors:  T J Crow
Journal:  Experientia       Date:  1982-11-15

Review 3.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

4.  Further studies of the cytopathic effect in tissue cultures inoculated with CSF from patients with schizophrenia and other nervous system diseases.

Authors:  D A Tyrrell; R Parry; H Davies; C Bloxham; T J Crow
Journal:  Br J Exp Pathol       Date:  1983-08

5.  Serotonin turnover rate in raphe and cortex of mice infected with Venezuelan equine encephalomyelitis virus.

Authors:  L Lima; R Walder; F Obregón; B Drujan
Journal:  J Neurosci Res       Date:  1987       Impact factor: 4.164

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.